Oncoclinicas do Brasil (ONCO3) — Cash Flow-to-Debt Ratio
Oncoclinicas do Brasil (ONCO3) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of R$151.75 Million could theoretically repay 0% of its total liabilities (R$7.02 Billion) in one year. Check ONCO3 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oncoclinicas do Brasil Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Oncoclinicas do Brasil across 12 annual periods. Also explore Oncoclinicas do Brasil (ONCO3) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Oncoclinicas do Brasil (2013–2024)
Year-by-year debt coverage analysis for Oncoclinicas do Brasil. For market capitalisation and broader financial context, see Oncoclinicas do Brasil (ONCO3) total market value.
| Year | CF-to-Debt Ratio | Operating CF (BRL) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.02x | R$-184.85 Million | R$7.82 Billion | ▼ -198.1% |
| 2023 | -0.01x | R$-51.56 Million | R$6.50 Billion | ▲ +83.7% |
| 2022 | -0.05x | R$-271.64 Million | R$5.59 Billion | ▼ -1852.2% |
| 2021 | 0.00x | R$-9.28 Million | R$3.73 Billion | ▼ -106.9% |
| 2020 | 0.04x | R$97.56 Million | R$2.71 Billion | ▼ -46.1% |
| 2019 | 0.07x | R$97.08 Million | R$1.45 Billion | ▲ +50.9% |
| 2018 | 0.04x | R$38.86 Million | R$878.19 Million | ▼ -81.9% |
| 2017 | 0.24x | R$135.26 Million | R$553.99 Million | ▲ +541.6% |
| 2016 | -0.06x | R$-20.71 Million | R$374.51 Million | ▼ -483.0% |
| 2015 | -0.01x | R$-3.10 Million | R$326.58 Million | ▼ -134.5% |
| 2014 | 0.03x | R$9.29 Million | R$338.17 Million | ▲ +1.8% |
| 2013 | 0.03x | R$7.34 Million | R$272.27 Million | — |